Effects of Evolocumab on Carotid Intima-Media Thickness and Clinical Parameters in Patients Taking a Statin

We determined the effects of evolocumab, a fully human monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9, on carotid intima-media thickness (IMT) and the factors associated with the change in carotid IMT in patients taking a statin. The change in carotid mean and maximum IM...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Keiji, Imamura, Shigeki, Hirai, Aizan, Ookawara, Susumu, Morishita, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408755/
https://www.ncbi.nlm.nih.gov/pubmed/32708615
http://dx.doi.org/10.3390/jcm9072256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408755/
https://www.ncbi.nlm.nih.gov/pubmed/32708615
http://dx.doi.org/10.3390/jcm9072256

Ejemplares similares